> 44- Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.Tensaouti F, Khalifa J, Lusque A, Plas B, Lotterie JA, Berry I, Laprie A, Cohen-Jonathan Moyal E, Lubrano V.
Neuroradiology. 2017 Oct;59(10):1013-1020. doi: 10.1007/s00234-017-1899-7. > 21- Subventricular zones: new key targets for glioblastoma treatment.Khalifa J, Tensaouti F, Lusque A, Plas B, Lotterie JA, Benouaich-Amiel A, Uro-Coste E, Lubrano V, Cohen-Jonathan Moyal E.
Radiat Oncol. 2017 Apr 20;12(1):67. doi: 10.1186/s13014-017-0791-2. > Corticospinal Tract Tracing in the Marmoset with a Clinical Whole-Body 3T Scanner Using Manganese-Enhanced MRI.Demain B, Davoust C, Plas B, Bolan F, Boulanouar K, Renaud L, Darmana R, Vaysse L, Vieu C, Loubinoux I.
PLoS One. 2015 Sep 23;10(9):e0138308. doi: 10.1371/journal.pone.0138308. > Strength and fine dexterity recovery profiles after a primary motor cortex insult and effect of a neuronal cell graft.Vaysse L, Conchou F, Demain B, Davoust C, Plas B, Ruggieri C, Benkaddour M, Simonetta-Moreau M, Loubinoux I.
Behav Neurosci. 2015 Aug;129(4):423-34. doi: 10.1037/bne0000067. > Stem cells and motor recovery after stroke.Loubinoux I, Demain B, Davoust C, Plas B, Vaysse L.
Ann Phys Rehabil Med. 2014 Nov;57(8):499-508. doi: 10.1016/j.rehab.2014.08.008. Review.